• Skip to main content
  • Skip to after header navigation
  • Skip to site footer
ERN: Emerging Researchers National Conference in STEM

ERN: Emerging Researchers National Conference in STEM

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Conference
  • Abstracts
    • Undergraduate Abstract Locator
    • Graduate Abstract Locator
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
  • Travel Awards
  • Resources
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • Login

Isa Watson

February 8, 2019 by dawn

CEO & Founder, Envested
Envested

Isa Watson is the Founder and CEO of Squad by Envested, a data-driven software company revolutionizing how people create meaningful connections across their work-life experience. Named in Inc Magazine’s “30 under 30” list in 2017, Squad by Envested has also been featured in Forbes, Bloomberg, Fast Company, Inc and Entrepreneur.com. The company receives backing by notable Silicon Valley VC firms, like Harrison Metal and Precursor VC with enterprise customers companies like Walmart.com, Jet and WeWork.
Isa earned an MBA from the Massachusetts Institute of Technology, a M.S. in Pharmacology from Cornell University and a B.S. in Chemistry from Hampton University, where she was an American Chemical Society and National Science Foundation Scholar. Before founding Squad, Isa was a Vice President of Digital Strategy at JPMorgan Chase (JPMC) in New York and Hong Kong, where she worked closely with senior management to build and execute various strategic initiatives across product development, analytics, marketing and client services across various JPMC businesses. Prior to this, Isa worked at Pfizer both as a research chemist and as a clinical trial strategy analyst. In the research group, she developed drug candidates for diabetes treatment, with her work on glucokinase activators published in Tetrahedron Letters. In the clinical group, she designed and executed statistical analyses to inform and support the global clinical strategies for Lyrica® in over 15 countries.

All Conference Speakers

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW
Washington,DC 20005
202-326-6400
Contact Us
About Us

  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube

The World’s Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

Focus Areas

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law

© 2023 American Association for the Advancement of Science